Cart
sales@molnova.com
MART-1 (26-35) human
CAS No. 156251-01-3
MART-1 (26-35) human ( —— )
Catalog No. M21016 CAS No. 156251-01-3
MART-1 (26-35) human is amino acid residue 26 to 35 of MART-1 protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 308 | In Stock |
|
| 10MG | 462 | In Stock |
|
| 25MG | 686 | In Stock |
|
| 50MG | 1017 | In Stock |
|
| 100MG | 1377 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMART-1 (26-35) human
-
NoteResearch use only not for human use.
-
Brief DescriptionMART-1 (26-35) human is amino acid residue 26 to 35 of MART-1 protein.
-
DescriptionMART-1 (26-35) human is amino acid residue 26 to 35 of MART-1 protein.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number156251-01-3
-
Formula Weight943.1
-
Molecular FormulaC42H74N10O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC(C)C(NC(=O)CNC(=O)C(C)NC(=O)C(C)NC(=O)C(N)CCC(=O)O)C(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)O)C(C)C)C(C)O)C(C)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Borbulevych O Y Insaidoo F K Baxter T K et al. Structures of MART-126/27–35 Peptide/HLA-A2 Complexes Reveal a Remarkable Disconnect between Antigen Structural Homology and T Cell Recognition[J]. Journal of Molecular Biology 2007 372(5):0-1136.
molnova catalog
related products
-
Ibiglustat
An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access.
-
1H-1-ethyl Candesart...
1H-1-ethyl Candesartan Cilexetil is a process-related impurity in the bulk synthesis of candesartan cilexetil, which is a potent, long-acting and selective angiotensin II type 1 receptor (AT1) antagonist.
-
N-Boc-Phe-Leu-Phe-Le...
N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
